Guidance Document: Labelling of Pharmaceutical Drugs for Human Use
The purpose of this document is to provide guidance to sponsors to facilitate compliance with the labelling requirements pursuant to sections 3, 9, and 10 of the Food and Drugs Act as well as related provisions of the Food and Drug Regulations and the Controlled Drugs and Substances Act.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Guidance Document: Labelling of Pharmaceutical Drugs for Human UseHTMLEnglish publication HTML
-
Guidance Document: Labelling of Pharmaceutical Drugs for Human UseHTMLFrench publication HTML
Similar records